SCHEMBL6317637

SCHEMBL6317637

COc1cc(CC(O)CN2CCN(CC(=O)Nc3c(C)cccc3C)CC2)cc(OC)c1OC

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.67
TSHR P16473 2/20 0.67
CYP2D6 P10635 2/20 0.67
ADRB1 P08588 2/20 0.67
ADRA2A P08913 2/20 0.67
ADRA2B P18089 2/20 0.67
ADRA2C P18825 2/20 0.67
ADRA1A P35348 2/20 0.67
DRD3 P35462 2/20 0.67
HTR2B P41595 2/20 0.67
KCNH2 Q12809 2/20 0.67
NFKB1 P19838 1/20 0.67
ADRB2 P07550 1/20 0.67
SCN5A Q14524 1/20 0.67
LMNA P02545 3/20 0.66
BLM P54132 1/20 0.66
PMP22 Q01453 1/20 0.66
NPSR1 Q6W5P4 1/20 0.66
DRD4 P21917 3/20 0.46
ALDH1A1 P00352 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4492926 0.90 CYP3A4 (0.57) CYP3A4TSHRCYP2D6ADRB1ADRA2A
SCHEMBL7292391 0.89 CYP3A4 (0.76) CYP3A4TSHRCYP2D6ADRB1ADRA2A
SCHEMBL6283413 0.86 CYP3A4 (0.49) CYP3A4TSHRCYP2D6ADRB1ADRA2A
SCHEMBL3827741 0.85 ADRA1A (0.62) CYP3A4TSHRCYP2D6ADRB1ADRA2A
SCHEMBL6284296 0.85 CYP2D6 (0.64) CYP3A4TSHRCYP2D6ADRB1ADRA2A
SCHEMBL6276948 0.84 CYP3A4 (0.75) CYP3A4TSHRCYP2D6ADRB1ADRA2A
SCHEMBL6286482 0.83 CYP3A4 (0.64) CYP3A4TSHRCYP2D6ADRB1ADRA2A
SCHEMBL12598795 0.82 CYP3A4 (0.70) CYP3A4TSHRCYP2D6ADRB1ADRA2A
Ranolazine SCHEMBL1495098 0.80 CYP3A4 (1.00) CYP3A4TSHRCYP2D6ADRB1ADRA2A
Ranolazine SCHEMBL124666 0.80 CYP3A4 (1.00) CYP3A4TSHRCYP2D6ADRB1ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6552023-B2 N-(2,6-dimethylphenyl)-2-(4-(2-hydroxy-4-phenylbutyl) -piperazinyl)acetamide, for example; useful to protect skeletal muscles against damage from trauma or disease, treat shock, preserve donor tissue or organs; greater half-life CV THERAPEUTICS, INC. 2003-04-22 US claimed
US-6852723-B2 Aralkyl substituted piperazine compounds CV THERAPEUTICS, INC. (US) 2005-02-08 US disclosed